Medicare Enrolled
Dr. Shahed Quyyumi, MD
Endocrinology · Staten Island, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Quyyumi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Quyyumi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Quyyumi
Dr. Shahed Quyyumi is an endocrinology specialist in Staten Island, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Quyyumi performed 2,027 Medicare services across 1,505 unique beneficiaries.
Between the years covered by Open Payments, Dr. Quyyumi received a total of $203,313 from 66 pharmaceutical and/or device companies across 1734 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Quyyumi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 26% volume in NY
$203,313 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,027
Medicare services
Top 26% in NY for endocrinology
1,505
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~101 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
726 | $102 | $314 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
582 | $3 | $15 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
222 | $10 | $60 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
206 | $94 | $371 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $78 | $214 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
92 | $140 | $487 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
31 | $12 | $76 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
22 | $72 | $175 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
22 | $36 | $55 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $84 | $322 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$203,313
Total received (2018-2024)
Avg $29,045/year across 7 years
Top 4% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
1,734
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$172,477 (84.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,962 (12.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,875 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,814
2023
$10,718
2022
$25,898
2021
$43,216
2020
$34,748
2019
$28,450
2018
$56,469
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$560
Amgen Inc.
$461
Lilly USA, LLC
$308
Radius Health, Inc.
$288
Mannkind Corporation
$256
Boehringer Ingelheim Pharmaceuticals, Inc.
$224
Insulet Corporation
$202
Intra-Sana Laboratories
$180
Corcept Therapeutics
$177
Abbott Laboratories
$164
AstraZeneca Pharmaceuticals LP
$151
SANOFI-AVENTIS U.S. LLC
$143
PFIZER INC.
$97
Dexcom, Inc.
$92
Amneal Pharmaceuticals LLC
$89
Bayer Healthcare Pharmaceuticals Inc.
$84
ABBVIE INC.
$66
Chiesi USA, Inc.
$54
Xeris Pharmaceuticals, Inc.
$40
Tolmar, Inc.
$33
Echosens North America, Inc.
$27
Neurocrine Biosciences, Inc.
$27
Ascendis Pharma Inc
$23
Esperion Therapeutics, Inc.
$19
Amphastar Pharmaceuticals, Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
CeQur Corporation
$14
Top 3 companies account for 34.8% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$69,960
AstraZeneca Pharmaceuticals LP
$61,478
SANOFI-AVENTIS U.S. LLC
$24,828
Lilly USA, LLC
$16,905
Janssen Pharmaceuticals, Inc
$5,359
Novo Nordisk Inc
$4,168
Amgen Inc.
$3,387
Medtronic MiniMed, Inc.
$2,926
Insulet Corporation
$1,442
Mannkind Corporation
$974
PFIZER INC.
$972
Dexcom, Inc.
$918
Merck Sharp & Dohme Corporation
$776
MannKind Corporation
$756
Radius Health, Inc.
$725
Amneal Pharmaceuticals LLC
$689
Abbott Laboratories
$637
AbbVie Inc.
$445
Bayer HealthCare Pharmaceuticals Inc.
$436
Bayer Healthcare Pharmaceuticals Inc.
$412
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$409
Merck Sharp & Dohme LLC
$400
Corcept Therapeutics
$380
ABBVIE INC.
$347
Xeris Pharmaceuticals, Inc.
$298
Ipsen Biopharmaceuticals, Inc
$294
Esperion Therapeutics, Inc.
$237
Medtronic, Inc.
$212
Becton, Dickinson and Company
$188
Valeritas, Inc.
$181
Intra-Sana Laboratories
$180
Amryt Pharma Holdings Ltd
$175
Novartis Pharmaceuticals Corporation
$168
GRT US Holding, Inc.
$140
AbbVie, Inc.
$135
IBSA Pharma Inc.
$134
Tolmar, Inc.
$121
DEXCOM, INC.
$115
Horizon Therapeutics plc
$91
Ascendis Pharma Inc
$89
Shire North American Group Inc
$75
Amarin Pharma Inc.
$71
Embecta Corp.
$64
Chiesi USA, Inc.
$54
LifeScan, Inc.
$42
EISAI INC.
$42
Tandem Diabetes Care, Inc.
$38
Ultragenyx Pharmaceutical Inc.
$35
Intuity Medical Inc
$33
VistaPharm, Inc.
$33
RECORDATI_RARE_DISEASES_INC.
$32
SANOFI PASTEUR INC.
$31
Regeneron Healthcare Solutions, Inc.
$30
CeQur Corporation
$28
Echosens North America, Inc.
$27
Neurocrine Biosciences, Inc.
$27
Eisai Inc.
$25
Kyowa Kirin, Inc.
$23
OPKO Pharmaceuticals, LLC
$20
Amphastar Pharmaceuticals, Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
Strongbridge US INC.
$15
Antares Pharma, Inc.
$15
Advanced Oxygen Therapy Inc.
$14
Ferring Pharmaceuticals Inc.
$11
Clarus Therapeutics Inc.
$6
Top 3 companies account for 76.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ASMANEX · Aimovig · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BEVESPI AEROSPHERE · BRILINTA · Belviq · CRYSViTA · CYCLOSET · CeQur Simplicity · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom CGM · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUMET · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · LOKELMA · LYRICA · LYUMJEV · Levemir · MACRILEN · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · Norditropin · Omnipod · OneTouch · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · Pogo Automatic Blood Glucose Monitoring System · Prolia · Qutenza · RECORLEV · RELTONE 200 MG · RETEVMO · RYBELSUS · Rayaldee · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Sogroya · Somatuline Depot · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · VERQUVO · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · ZOMACTON · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for endocrinology in NY.
Geographic Context
Endocrinologists within 10 mi
664
Per 100K population
134.8
County median income
$98,290
Nearest hospital
RICHMOND UNIVERSITY MEDICAL CENTER
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Quyyumi is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NY), with speaking/promotional industry engagement in the top 4% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Quyyumi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Quyyumi performed 726 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Quyyumi receive payments from pharmaceutical companies?
Yes. Dr. Quyyumi received a total of $203,313 from 66 companies across 1,734 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Quyyumi's costs compare to other endocrinologists in Staten Island?
Dr. Quyyumi's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Quyyumi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Staten Island
Browse endocrinologists in Staten Island ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology